Investmentcure

Terms & Condition Terms & Condition

Disclaimer

  • Saurab Jain Proprietor of Investment Cure Research is a SEBI registered Research Analyst (Registration No. INH000012838) under the SEBI (Research Analysts) Regulations, 2014.
  • Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
  • The securities quoted are for illustration only and are not recommendatory.
  • Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
  • INVESTMENT CURE RESEARCH(Research Analyst) owns the website www.InvestmentCure.com (“website/ INVESTMENT CURE RESEARCH(Research Analyst) “).
  • INVESTMENT CURE RESEARCH(Research Analyst) makes research-based recommendations on various opportunities in the Indian equity market for the short and long term. ( By Technical Analysis or Fundamental Analysis or both )
  • We have never been suspended or barred from doing business by SEBI or any other authority, nor has SEBI ever cancelled our certificate of registration.
  • The firm does not provide merchant banking, investment banking, investment adviser, or brokerage services.
  • We have not partnered with any third-party intermediaries for execution or distribution services. As a result, we receive no compensation for execution or distribution services.
  • Please see the individual recommendation reports for information on ownership, material conflicts of interest, and compensation received.
  • The recommendations should not be interpreted as a solicitation of an offer to purchase or sell any security in a jurisdiction were doing so would be against the law.
  • Regarding the accuracy, timeliness, or completeness of the information (including news, pricing, statistics, analysis, and the like) offered through our website, www.investmentcure.com INVESTMENT CURE RESEARCH(RESEARCH ANALYST) makes no representation, warranty, or guarantee. INVESTMENT CURE RESEARCH(RESEARCH ANALYST) and its affiliates are not responsible for any decisions made or actions performed as a result of using the information provided here. Access to the material on this website isn’t meant to be and shouldn’t be seen as an offer to purchase or sell any security. It also shouldn’t be seen as establishing any kind of contractual relationship between INVESTMENT CURE RESEARCH(RESEARCH ANALYST) and anybody who uses or acts on the information on this website. This website’s original writing, including but not limited to the design, text, and images, are protected as intellectual property and may not be used in whole or in part in any way by copying, reproducing, transmitting, displaying, or otherwise. While every effort has been made to ensure the authenticity of this website, Saurab Jain Proprietor of Investment Cure Research(Research Analyst), its employees, and authorised representatives disclaim all liability for any person or entity who directly or indirectly suffers consequential losses, damages, or claims of any kind as a result of any flaw, error, or inaccuracy that unintentionally crept into this website or uses the information on this website in any other way. Despite all reasonable precautions taken by INVESTMENT CURE RESEARCH(RESEARCH ANALYST) to prevent hacking and other interference, this website is not immune to these risks. As with any other website, INVESTMENT CURE RESEARCH(RESEARCH ANALYST) disclaims all responsibility for any loss or damage a user may experience as a result of any alteration or manipulation of any data or information accessed through or downloaded from this website.
  • The information and data on www.InvestmentCure.com, including but not limited to recommendations, past performance, stock ratings, and research rationale, are provided solely for educational and illustrative purposes. The performance figures are calculated using a standard methodology and do not account for transaction fees or other related costs. INVESTMENT CURE RESEARCH(Research Analyst) has not audited or validated the data used to calculate historical returns and other information, which is provided by exchange- approved third-party data vendors.
  • All information available on www.InvestmentCure.com, are intended to assist investors with their decision-making and should not be construed as a recommendation or solicitation for a particular investment or investment plan. Investors are accountable for their investing decisions and for validating any information used to make those decisions. Investors should recognize that their investment decisions are based on their individual financial needs, and that the performance information available on www.investmentcure.com is just one of many factors that should be considered before making an investment decision. Past performance is not indicative of future results, and the performance of www.investmentcure.com services is subject to market risk. Before investing, investors should carefully examine all relevant papers, such as research reports, financial statements, etc., as investments in the securities market are susceptible to market risks. Derivatives are sophisticated financial instruments. Before actually trading in derivative contracts, the investor is required to analyze all relevant risk considerations.
  • In no way does INVESTMENT CURE RESEARCH (Research Analyst) promise or guarantee a favourable outlook for a particular industry, sector, or business group. Before investing, the investor must assess all risk variables, including their financial position.
  • The analysts/representatives for various Research recommendations certify that all information/material therein accurately reflects their personal opinions about the subject company or companies and their securities, and that no portion of their compensation has been, is being, or will be related in any way to the company they recommend in their research analyses/reports. No part of this content may be copied or transferred in any way without the Investment Cure Research (Research Analyst)/ www.investmentcure.com prior written approval.

Acceptance of this disclosure and disclaimer report is implied by the act of browsing and reading the content. Strictly Reserved.

Correspondence address Office no-223 Krishna Business Centre Near Medanta Road, Malviya Nagar -Indore (M.P) Registered office of INVESTMENT CURE RESEARCH(RESEARCH ANALYST) , Omkar Complex Building No A2,  No 101 , A-Wing, Shahad Kalyan Thane- 421301 Maharashtra. Contact us on support@InvestmentCure.com

Disclouser

The particulars given in this Disclosure Document have been prepared in accordance with
SEBI (Research Analyst) Regulations, 2014.

The purpose of the Document is to provide essential information about the Research and
recommendation Services in a manner to assist and enable the perspective client/client in
making an informed decision for engaging in Research and recommendation services
before investing.

For the purpose of this Disclosure Document, Research Analyst is Saurab Jain ,
Proprietor of Investment Cure Research, (hereinafter referred as “Research Analyst”)

Descriptions about “Research Analyst”

History, Present business and Background
Saurab Jain Proprietor of Investment Cure Research (Research Analyst) is registered with
SEBI as Research Analyst with Registration No. INH000012838. The firm got its registration
on Aug 31, 2023 and is engaged in research and recommendation Services.

The focus of Research Analyst is to provide research and recommendations services to the
clients. Analyst aligns its interests with those of the client and seeks to provide the best
suited services.

Disciplinary history

No penalties / directions have been issued by SEBI under the SEBI Act or
Regulations made there under against the Research Analyst relating to Research
Analyst services.

There are no pending material litigations or legal proceedings, findings of inspections
or investigations for which action has been taken or initiated by any regulatory
authority against the Research Analyst or its employees.

Details of its associates

No associates

Disclosures with respect to Research and Recommendations Services
  • Research Analyst may have financial interest or actual / beneficial ownership in the
    securities recommended in its personal portfolio. Details of the same may be
    referred through the disclosures made at the time of recommendation.
  • There are no actual or potential conflicts of interest arising from any connection to or
    association with any issuer of products/ securities, including any material information
    or facts that might compromise its objectivity or independence in the carrying on of
    Research Analyst services. Such conflict of interest shall be disclosed to the client
    as and when they arise.
  • Research Analyst or its employee or its associates have not received any
    compensation from the subject company in past 12 months.
  • Research Analyst or its employee or its associates have not managed or co-
    managed the public offering of Subject Company in past 12 months.
  • Research Analyst or its employee or its associates have received any compensation
    for investment banking or merchant banking of brokerage services from the subject
    company in past 12 months.
  • Research Analyst or its employee or its associates have not received any
    compensation for products or services other than above from the subject company in
    past 12 months.
  • Research Analyst or its employee or its associates have not received any
    compensation or other benefits from the Subject Company or 3rd party in connection
    with the research report/ recommendation.
  • The subject company was not a client of Research Analyst or its employee or its
    associates during twelve months preceding the date of distribution of the research
    report and recommendation services provided.
  • Research Analysts or its employee or its associates has not served as an officer,
    director or employee of the subject company.
  • Research Analysts has not been engaged in market making activity of the subject
    company

Terms & Condition

Terms & condition : Before subscribing our any of the services we advise you to please visit our website www.investmentcure.com and read all terms & conditions carefully. By subscribing our any of the services you agree to be bound by the terms & conditions. We may change these terms and conditions at any time without prior information/intimation. Your continuous use of www.investmentcure.com means that you accept any new or modified terms and conditions that we come up with. Please re-visit the `Terms & Conditions’ link at our website from time to time to stay abreast of any changes that we may introduce. Investment/trading in Securities and commodities are subject to market and other risks and there is no assurance or guarantee that the objectives of any Services will be achieved. Traders/Investors in the services are not being offered any guaranteed/assured returns. Past performance of the services does not indicate/guarantee of the future performance or return for any of the services. We do not have any refund & cancellation policy. All sales are final. Before subscriptions ensure that our products and services will meet your needs without the need to purchase, there will be absolutely no refund & cancellations. We do not offer refunds on subscriptions that have already been taken. By registering for service on website www.investmentcure.com you have accepted all the terms and conditions. For service activation you have to complete (know your client) as per SEBI guidance. If you fail to complete KYC you will be only responsible for delay in services. Investment cure Research (Research Analyst) (Research Analyst) will not be responsible for same. Investment cure Research (Research Analyst) (Research Analyst) only communicates with our clients regarding services and all other matters through official emails (having our domain “investmentcure.com“), kindly do not accept any other email which does not contain the domain (investmentcure.com) clearly. Investment cure Research (Research Analyst) (Research Analyst) which never trade on behalf of the subscriber. Also any amount paid to us is only a subscription charge paid to avail our Research Analyst services of market related recommendations. The Amount of fee is the consideration for our services. We received your express and implied consent on the point that Fee is reasonable and fair for you. We are not bound and liable for your market loss because the market is full of risk. Execution of services is not our concern. Service once started can’t stop/hold. We provide Research Recommendation through SMS or Mail  or Messenger only. Please do not trade on the Research Recommendation which is not provided through SMS or Mail or messenger. We never provide service like profit sharing, guaranteed profit, Sure shot, Jackpot etc. Trading & investments are subject to market risks.  Investment cure Research (Research Analyst) (Research Analysts) will not be responsible for any failure to receive service Research Recommendation via SMS (Short Message Service) if a client’s number is on the Do Not Disturb (DND) list or if there are technical issues. Clients are advised to ensure they are able to receive SMS service Research Recommendation by checking their settings and DND status with their telecom service provider. Investment cure Research (Research Analyst) (Research Analysts) is responsible only for sending communications via SMS, email, or messenger. In cases where clients do not receive service recommendation due to incorrect email address or phone numbers provided by them, Investment cure Research (Research Analyst) (Research Analysts) cannot be held liable for any undelivered sms or e -mail that occur due to any unwanted technical issue. We have opened our current account by name of “Investment Cure Research “(Proprietor Saurab Jain) PAN Number-AHLP*8***P. ( as PAN Number shared with SEBI ). We only take service fees only in our current account having account of “Investment Cure Research “(Proprietor Saurab Jain) PAN Number-AHLP*8***P. If anyone from Investment cure Research (Research Analyst) or any other person who said that I am from Investment Cure Research ( Research Analyst )ask to pay fees in other account please inform us immediately. We will not be liable for any liabilities for payment which make apart from our current account. We will not be responsible for any other payment. Report us on support@investmentcure.com

RISK DISCLOSURE: Stock trading is inherently risky. Prior to trading securities and commodities you must be aware of the risks involved. The high degree of leverage associated with these types of investments means that the degree of risk compared to other financial products is higher. Leverage (or margin trading) may work against you resulting insubstantial loss. Past performance[s] of these types of investments does not guarantee any future results. You must bear in mind any commission and tax liabilities you personally will have from investing on our Research Recommendation. Investment cure Research (Research Analyst)(Research Analysts) accepts no liability for any loss/tax/commission/brokerage you may be required to pay on any profits/loss made during the service tenure with us. Trading on Margin involves a high level of risk and is not suitable for all investors. The high degree of leverage can work against you as well as for you and the speeds which profits and losses can occur, means that clients should monitor positions closely – it is the clients’ sole responsibility to monitor open trades. Before trading, you should carefully consider your investment objectives, level of financial experience, risk appetite and suitability of service offered by Investment cure Research (Research Analyst). If you are at all unsure as to the suitability of the products offered by Investment cure Research (Research Analyst). Please seek other/independent financial adviser. Only surplus funds should be placed at risk and anyone who does not have such funds should not participate in trading securities and commodities.Trading & investments are subject to market risks